CA 051
Alternative Names: CA-051Latest Information Update: 28 Oct 2024
Price :
$50 *
At a glance
- Originator Concentric Analgesics
- Class Non-opioid analgesics; Small molecules
- Mechanism of Action TRPV1 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer pain; Postoperative pain
Most Recent Events
- 28 Oct 2024 No recent reports of development identified for preclinical development in Cancer-pain in USA (Epidural, Injection)
- 28 Oct 2024 No recent reports of development identified for preclinical development in Postoperative-pain in USA (Epidural, Injection)
- 23 Sep 2020 Preclinical trials in Cancer pain in USA (unspecified route) (Concentric Analgesics pipeline September 2020)